Three-dimensional adipose-derived stem cell spheroids enhance adipogenesis and angiogenesis in fat grafts: experimental research Authors: Sang-Oh Lee, Bo-Yoon Park, Tiep Tien Nguyen, Kyoo-Ri Kwon, Mi-Jin Kim, Hae Young Yang, Jay Kim, Jee-Heon Jeong, Il-Kug Kim Published: 2024 Highlights 3D-ASC spheroids (3D-ASCs) demonstrated enhanced adipogenic and angiogenic potentials, as well as increased hypoxic resistance, with a significant reduction in inflammatory markers compared to 2D-ASCs in vitro. 3D-ASC spheroids (3D-ASCs) demonstrated enhanced adipogenic and angiogenic potentials, as well as increased hypoxic resistance, with a significant reduction in inflammatory markers compared to 2D-ASCs in vitro. Immunofluorescence assay verified increased viability and integration of adipocytes, along with increased vascular density, in fat grafts treated with 3D-ASCs. Immunofluorescence assay verified increased viability and integration of adipocytes, along with increased vascular density, in fat grafts treated with 3D-ASCs. Gene set enrichment analysis revealed upregulation of beneficial molecular pathways for adipogenesis and angiogenesis, alongside downregulation of inflammation, hypoxia, and fibrosis in the 3D-ASC group. Gene set enrichment analysis revealed upregulation of beneficial molecular pathways for adipogenesis and angiogenesis, alongside downregulation of inflammation, hypoxia, and fibrosis in the 3D-ASC group. Dear Editor, Cell-assisted lipotransfer (CAL) improves traditional fat transfer by mixing adipose-derived stem cells (ASCs) with harvested fat to enhance graft survival. Some of the ASCs from liposuctioned fat differentiate into adipocytes and endothelial cells, boosting adipogenesis and angiogenesis1. Notably, 3D-cultured ASC spheroids (3D-ASCs) show higher viability compared to 2D-cultured ASCs (2D-ASCs) due to better cell–cell and cell–matrix interactions, improving ischemic resistance, angiogenic factor secretion, and nutrient distribution2. Despite evidence from studies, He et al.3 and El Harane et al.4 showing that CAL with 3D-ASCs enhances fat graft survival through increased adipogenesis and angiogenesis; these studies were based on protein or microarray analyses. To further support these findings and understand the molecular mechanisms, we performed in-vitro experiments, tracked GFP-expressing ASCs, and conducted comprehensive RNA sequencing analysis. The methods for the in-vitro and in-vivo experiments and statistical analyses are provided in the Supplementary Text (Supplemental Digital Content 1, http://links.lww.com/JS9/D491). The primer sequences used for RT-PCR analysis in the in-vitro experiments are listed in Supplementary Table S1 (Supplemental Digital Content 2, http://links.lww.com/JS9/D492). In-vitro experiments, 3D-ASCs were created using the AggreWell 24-well system with 1×106 cells per well, resulting in spheroids containing 850±32 cells each. After 24 h, these spheroids averaged 182±15 μm in diameter. Live/dead staining revealed only a few scattered dead cells and flow cytometry confirmed high cell viability, with 90.40±2.64% of the cells being viable (Fig. 1A–D). 3D-ASCs significantly enhanced the expression of crucial angiogenic factors (Fgfb, Igf, and Hgf), anti-inflammatory cytokines (Il10 and Tgfb), and adipogenic differentiation markers (Cebpa and Pparg) (Fig. 1E). As fat grafts are often subjected to inflammation and hypoxia in the transplanted area, leading to early cell death, volume shrinkage, and low retention rates, we designed in-vitro experiments to assess the protective effect of ASCs on 3T3-L1 preadipocytes under inflammation and hypoxic conditions involving either macrophage co-culture or 1% oxygen (Fig. 1F, L). Under inflammatory conditions, intracellular ROS production, gene expression, and protein levels of pro-inflammatory cytokines IL-1β and IL-6 were assessed in preadipocytes. IL-1β gene expression was significantly lower in the 3D-ASC treated group (Fig. 1G–K). Under hypoxic conditions, 3D-ASCs exhibited superior effects compared to 2D-ASCs, reducing ROS, Casp3 gene level, and Caspase 3/7 activity (Fig. 1M–O). Overall, these results suggest that 3D-ASCs may have greater potential than 2D-ASCs for exerting adipogenic, angiogenic, and anti-inflammatory effects, as well as for providing enhanced resistance to hypoxia-induced oxidative stress and apoptosis. Inhibition of inflammatory response and oxidative stress in preadipocytes in co-culture systems with 3D-ASCs. (A) Illustration of 3D-ASC fabrication using AggreWell culture. The cells underwent incubation in the AggreWell at 37°C with 5% CO2 for 6 h. The obtained spheroids were collected and cultured in a non-adhesive Petri dish for an additional 24 h before evaluation. (B) 3D-ASC size distribution, measured using ImageJ. (C) Live/dead staining assay with AO/PI. (D) Quantitative viability assay, using flow cytometry analysis. (E) Gene expression profiles of ASCs in 2D and 3D culture. (F) Illustration of the 24-hour co-culture system containing 3T3-L1 preadipocytes, RAW 264.7 macrophages, and 2D/3D-ASCs. (G) Intracellular ROS production in preadipocytes was determined using a DCF-DA reaction assay. (H, I) Inflammatory gene expression in preadipocytes was determined using RT-PCR. (J, K) Inflammatory cytokine levels in preadipocytes were determined using ELISA kits. (L) Illustration of the 24-hour co-culture system containing 3T3-L1 preadipocytes and 2D/3D-ASCs under hypoxic conditions (1% O2). (M) Intracellular ROS production in preadipocytes was determined using a DCF-DA reaction assay. (N) Apoptotic Casp3 gene expression in preadipocytes was determined using RT-PCR. (O) Caspase 3/7 activity in preadipocytes was determined using a Caspase-Glo 3/7 assay kit. The data in Figure 1E was analyzed using an unpaired two-tailed t-test, and those in Figures 1G–K and 1M–O were analyzed using a one-way ANOVA test combined with a two-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli analysis. n.s., non-significant, *P<0.05, **P<0.01, # P<0.001, $ P<0.0001. In an in vivo experiment using a murine fat graft model (Fig. 2A), 8 weeks after fat grafting, both the residual fat graft volume and ASC retention in the grafted fat were significantly greater in the 3D-ASCs group compared to the 2D-ASCs group (Fig. 2B–E). These results suggest that 3D-ASC supplementation enhances ASC retention within fat grafts, thereby improving the overall retention rate of fat grafts compared to 2D-ASC supplementation. Fat graft volume, GFP-positive adipose-derived stem cell (ASC) retention, viable adipocytes, and vascularity in grafted fat tissues. (A) Actual image showing 200 μl fat graft at the supraperiosteal plane. (B, C) Representative micro-CT images and quantification of graft volume in the control, 2D-ASC group, and 3D-ASC groups. (D, E) Representative immunofluorescent images and quantification of GFP-positive ASCs in the grafted fat tissues. (F, G) Representative images and quantification of perilipin-positive areas in the control, 2D-ASC group, and 3D-ASC group. (H, I) Representative images and quantification of vessel areas in the control, 2D-ASC group, and 3D-ASC group. (J, K) Representative images and quantification of perilipin and GFP co-positive cells in the 2D-ASC and 3D-ASC groups. (L, M) Representative images and quantification of CD31 and GFP co-positive cells in the 2D-ASC and 3D-ASC groups. Values are presented as mean±SD (n=7). Scale bars=200 or 100 μm. *P<0.05 and ***P<0.001 versus control. ## P<0.01 and ### P<0.001 versus the 2D-ASC group. Immunofluorescence assays, using perilipin and CD31 antibodies, revealed increased viable adipocytes and vascularity in the 3D-ASCs group compared to the 2D-ASCs group (Fig. 2F–I). Additionally, the number of cells co-expressing GFP with perilipin or CD31, indicative of ASC differentiation into adipocytes or endothelial cells, was significantly higher in the 3D-ASCs group (Fig. 2J–M). These findings indicate that 3D-ASCs facilitate a greater degree of differentiation into adipocytes and endothelial cells than 2D-ASCs, thereby enhancing adipogenesis and angiogenesis in fat grafts. To further investigate the molecular mechanisms behind enhanced adipogenesis and angiogenesis, bulk RNA sequencing was performed. Differential gene expression analysis identified 50 upregulated and 50 downregulated genes in the 3D-ASC group compared to the 2D-ASC group, as shown in the heatmap (Fig. 3A). The volcano plot revealed 215 significantly upregulated and 242 downregulated genes (Fig. 3B, Supplementary Table S2, Supplemental Digital Content 3, http://links.lww.com/JS9/D493). Gene set enrichment analysis indicated higher expression of pathways related to adipogenesis, fatty acid metabolism, oxidative phosphorylation, and peroxisomes in the 3D-ASC group, while pathways associated with TNF-α signaling, hypoxia, inflammation, and epithelial–mesenchymal transition (EMT) were downregulated (Fig. 3C, D, Supplementary Table S3, Supplemental Digital Content 4, http://links.lww.com/JS9/D494). Considering both in-vitro and in-vivo results and the fact that the interaction between peroxisomes and mitochondria in adipocytes protects the cells from ROS and generates PPARγ ligands through polyunsaturated fatty acid metabolism, this process is believed to promote adipogenesis by activating the C/EBPα-PPARγ axis5. Furthermore, considering the link between fatty acid metabolism and angiogenesis, free fatty acids from grafted fat are oxidized in endothelial cell mitochondria, enhancing angiogenesis through the mTORC1 pathway, which was upregulated in the 3D-ASC group (data not shown, NES: 1.34, FDR: 0.075, P<0.05). Fatty acid oxidation also boosts ATP production through oxidative phosphorylation under glucose depletion, increasing the resistance to oxidative stress6. The reduced expression of hypoxia, inflammation, and EMT pathways suggests better resistance to oxidative stress and lower inflammation, potentially inhibiting fibrosis progression. This corresponds with immunofluorescence assay results showing decreased M1 macrophages (pro-inflammatory) and increased M2 macrophages (anti-inflammatory), along with reduced HIF-1α expression, typically promoted under hypoxic conditions (Supplementary Fig. S1, Supplemental Digital Content 5, http://links.lww.com/JS9/D495). Comparative transcriptomic analysis. (A) Heatmaps showing relative expression patterns of significantly differentially expressed genes in the 2D-ASC group (2D-ASC) and 3D-ASC group (3D-ASC) (n=4 each) with hierarchical clustering (top 50 and bottom 50 genes). (B) Volcano plots showing the gene expression profiles between 2D-ASC and 3D-ASC. Genes with |Fold change| ≥2 and raw P value <0.05 were considered significantly differentially expressed between the two groups. (C) A representative gene set enrichment analysis (GSEA) plot showing significantly highly activated MH (Mouse Hallmark) pathways in 3D-ASC. (D) Representative gene set enrichment analysis plot showing significantly less activated MH pathways in 3D-ASC. Pathways with FDR <0.10 and P value <0.05 were considered significantly differentially activated between the two groups. Note that adipogenesis was promoted and inflammation-related pathways including TNF-α signaling and inflammatory response were suppressed in 3D-ASC. FDR, false discovery rate; NES, normalized enrichment score. The spheroid configuration of ASCs significantly enhances angiogenesis and adipogenesis, which are essential for effective adipose tissue engraftment and regeneration. Challenges in spheroid culture include the time needed to form stable spheroids and methods for large-scale production to ensure an adequate number for injection. Recently, we showed that stable and uniform spheroids can be efficiently generated within 2 h using a highly viscous methylcellulose medium7. Future advancements could include combining microwell technology, methylcellulose-based incubation, and automated production systems to enable large-scale spheroid manufacturing8–10. Microwell technology provides a simple, efficient, and standardized method for spheroid formation, which is noted for its ease and reproducibility. CAL using spheroid ASCs enhances fat graft retention rates with improved angiogenic, adipogenic, and immunomodulatory properties, carrying various clinical implications. This approach can reduce the need for reoperations, maintain practical procedure times, and improve patient satisfaction by enhancing overall outcomes and offering more effective treatment options. Additionally, it offers broad prospects for advancing regenerative medicine across various fields. To confirm its efficacy and evaluate long-term outcomes and potential complications, further large-scale cohort clinical trials are essential. Ethical approval All animal care and experimental procedures were approved by the Institutional Animal Care and Use Committee (No. YUMC-AEC2022-012) of the Yeungnam University College of Medicine, Republic of Korea. All experiments were performed from March 2021 to June 2023, following the relevant guidelines and regulations. Consent Not applicable. Source of funding This research was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2022R1A5A2018865 to Il-Kug Kim, and RS-2023-00272815 to Jee-Heon Jeong, RS-2024-00461644 to Bo-Yoon Park) and by a Korean Fund for Regenerative Medicine (KFRM) grant funded by the Ministry of Science and ICT and the Ministry of Health & Welfare (grant No. 23A0205L1 to Jee-Heon Jeong). Author contribution S.-O.L., B.-Y.P., T.T.N., J.-H.J., and I.-K.K.: designed the study; S.-O.L., B.-Y.P., T.T.N., K.-R.K., and M.-J.K.: performed the research and collected the data; S.-O.L., B.-Y.P., T.T.N., H.Y.Y., J.K., J.-H.J., and I.-K.K.: analyzed and interpreted the data; S.-O.L., B.-Y.P., T.T.N., J.-H.J., and I.-K.K.: wrote the first draft of the manuscript. All authors edited the manuscript and approved the final draft. Conflicts of interest disclosure The authors declared that they have no conflicts of interest in this work. Research registration unique identifying number (UIN) Not applicable. Guarantor Jee-Heon Jeong and Il-Kug Kim. Data availability statement The data generated and/or analyzed during this study are available from the corresponding authors on reasonable request. Provenance and peer review Not invited. Not commissioned, externally peer-reviewed. Supplementary Material SUPPLEMENTARY MATERIAL Acknowledgements The authors would like to thank Professor Injune Kim from the Korea Advanced Institute of Science and Technology for his assistance with RNA sequencing analysis. Footnotes S.-O.L., B.-Y.P., and T.T.N. contributed equally to this study. Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's website, www.lww.com/international-journal-of-surgery. Published online 30 September 2024 Contributor Information Sang-Oh Lee, Email: so9041@ynu.ac.kr. Bo-Yoon Park, Email: 311plpl@naver.com. Tiep Tien Nguyen, Email: tientiephup@gmail.com. Kyoo-Ri Kwon, Email: rnjsrbf93@naver.com. Mi-Jin Kim, Email: midal56@naver.com. Hae Young Yang, Email: hyyang1101@kaist.ac.kr. Jay Kim, Email: jaykim@kaist.ac.kr. Jee-Heon Jeong, Email: jeeheon@skku.edu. Il-Kug Kim, Email: curingyou@gmail.com. References Associated Data Supplementary Materials SUPPLEMENTARY MATERIAL Data Availability Statement The data generated and/or analyzed during this study are available from the corresponding authors on reasonable request.